Emerging Tx for AML

CE

Strategies for Secondary AML and Emerging Therapies for AML

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Nurses: 0.25 Nursing contact hour

Released: January 10, 2022

Expiration: January 09, 2023

Sara Tinsley-Vance
Sara Tinsley-Vance, PhD, MSN, APRN-BC, AOCN

Activity

Progress
1
Course Completed

In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses management strategies for secondary AML and novel therapies currently in clinical trials for AML. Topics include:

  • Liposomal cytarabine plus daunorubicin for secondary AML
  • An overview of emerging immune-based strategies for AML
  • Evidence on immune-based therapies, including agents targeting CD47, TIM3, and bispecific antibodies